A little over two years after Lyndra Therapeutics Inc. first unveiled its technology for time-delayed drug delivery through a simple pill, the company has raised $55 million to continue developing the technology for public consumption. By creating a new kind of ultra long-acting drug delivery mechanism in pills, the company claims it can remove the […]
View More Aiming to change the way people take medicine, Lyndra Therapeutics raises $55 millionCategory: Polaris Partners
Recent departures hint at turmoil at Quartet Health, a mental health startup backed by GV
Quartet Health, a startup backed with nearly $100 million from GV, Oak HC/FT and more, has quietly lost its COO, CPO and replaced its CEO this month.
View More Recent departures hint at turmoil at Quartet Health, a mental health startup backed by GVWhile tech waffles on going public, biotech IPOs boom
With our fixation on all things tech, we’re missing out on the big picture — there are actually more biotech and healthcare startup IPOs than tech offerings.
View More While tech waffles on going public, biotech IPOs boom